Autism spectrum disorder (ASD) refers to a neurodevelopmental disorder that is characterized by difficulties with social communication and social interaction and restricted and repetitive patterns in behaviors, interests, and activities. By definition, the symptoms are present early on in development and affect daily functioning.
The diagnosis of Autism Spectrum Disorder (ASD) is based on diagnostic evaluations that often involve a team including a physician and a psychologist, and may include other disciplines such as speech and language pathology or occupational therapy. The current treatment options for the core symptoms of autism are limited to psychosocial therapies, such as applied behavior analysis. Applied behavior analysis is a treatment based on theories of learning and operant conditioning. It includes specific intervention targets, coupled with positive reinforcement (verbal praise, tokens, or edible rewards), with repetition of learning-trials as a key component.
Get FREE sample copy at:
https://www.delveinsight.com/sample-request/autism-spectrum-disorder-asd-market
The Autism Spectrum Disorder (ASD) market report also covers emerging drugs, current treatment practices, Autism Spectrum Disorder (ASD) market share of the individual therapies, current and forecasted Autism Spectrum Disorder (ASD) Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Autism Spectrum Disorder (ASD) treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Autism Spectrum Disorder (ASD) Market Key Facts
According to British Medical Association, it is estimated that there are around 700,000 people in the UK, including one in 100 children, with a diagnosis of autism spectrum disorder.
According to the US Centers for Disease Control and Prevention (CDC) approximately, 1 in 68 children in the United States have been diagnosed with Autism. Autism is the third most common developmental disability. Besides, according to one of the epidemiological studies by “Action for Autism,” the prevalence rate is 1.7 million (estimated rate of 1 in 250 children).
As per the study by Dietz et al. (2020), in the U.S., approximately 1.5 million children ages 3–17 years have been diagnosed with Autism Spectrum Disorder (ASD).
Key Benefits of Autism Spectrum Disorder (ASD) Market Report
-
Autism Spectrum Disorder (ASD) market report provides an in-depth analysis of Autism Spectrum Disorder (ASD) Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.
-
The Autism Spectrum Disorder (ASD) market report will help in developing business strategies by understanding the Autism Spectrum Disorder (ASD) Market trends & developments, key players, and future market competition that will shape and drive the Autism Spectrum Disorder (ASD) market in the upcoming years.
-
The Autism Spectrum Disorder (ASD) market report covers Autism Spectrum Disorder (ASD) current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
-
The report provides a detailed assessment of the Autism Spectrum Disorder (ASD) market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Autism Spectrum Disorder (ASD) Market
Autism Spectrum Disorder (ASD) market size is expected to increase during the forecast period owing to the increasing prevalent population and growing awareness among the people through programs and initiatives in the 7MM.
The Autism Spectrum Disorder (ASD) market outlook section of the report helps to build a detailed comprehension of the historic, current and forecasted Autism Spectrum Disorder (ASD) market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Autism Spectrum Disorder (ASD) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Autism Spectrum Disorder (ASD) Epidemiology
The Autism Spectrum Disorder (ASD) epidemiology section covers insights about the historical and current Autism Spectrum Disorder (ASD) patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Autism Spectrum Disorder (ASD) Drugs Uptake and Key Market Players
The Autism Spectrum Disorder (ASD) Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Autism Spectrum Disorder (ASD) market or expected to get launched in the market during the study period. The analysis covers Autism Spectrum Disorder (ASD) market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Currently, no treatment has been shown to cure Autism Spectrum Disorder (ASD), but several interventions have been developed and studied for use with young children. These interventions may reduce symptoms, improve cognitive ability and daily living skills, and maximize the ability of the child to function and participate in the community.
The dynamics of the Autism Spectrum Disorders market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and also expects the launch of emerging therapies during the forecast period.
Autism Spectrum Disorder (ASD) Companies
Otsuka Pharmaceutical
Janssen Pharmaceutical
GW Research
Roche
Finch Therapeutics
And many others.
Autism Spectrum Disorder (ASD) therapies covered in the report include:
CM-AT
Brexpiprazole
JNJ-42165279
GWP42006
RO 7017773
CP101
And many more.
Table of Content
1. Key Insights
2. Executive Summary
3. Autism Spectrum Disorder (ASD) Competitive Intelligence Analysis
4. Autism Spectrum Disorder (ASD) Market Overview at a Glance
5. Autism Spectrum Disorder (ASD) Disease Background and Overview
6. Autism Spectrum Disorder (ASD) Patient Journey
7. Autism Spectrum Disorder (ASD) Epidemiology and Patient Population
8. Autism Spectrum Disorder (ASD) Treatment Algorithm, Current Treatment, and Medical Practices
9. Autism Spectrum Disorder (ASD) Unmet Needs
10. Key Endpoints of Autism Spectrum Disorder (ASD) Treatment
11. Autism Spectrum Disorder (ASD) Marketed Products
12. Autism Spectrum Disorder (ASD) Emerging Therapies
13. Autism Spectrum Disorder (ASD) Seven Major Market Analysis
14. Attribute Analysis
15. Autism Spectrum Disorder (ASD) Market Outlook (7 major markets)
16. Autism Spectrum Disorder (ASD) Access and Reimbursement Overview
17. KOL Views on the Autism Spectrum Disorder (ASD) Market.
18. Autism Spectrum Disorder (ASD) Market Drivers
19. Autism Spectrum Disorder (ASD) Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Related Reports
Autism Spectrum Disorder (ASD) Epidemiology Forecast
DelveInsight’s Autism Spectrum Disorder (ASD) – Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Autism Spectrum Disorder (ASD) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Autism Spectrum Disorder (ASD) Pipeline Insights
Autism Spectrum Disorder (ASD) Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Autism Spectrum Disorder (ASD) market.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd. 2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/